These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26029016)

  • 21. New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer.
    Evans DG; Woodward ER
    Fam Cancer; 2021 Jan; 20(1):1-7. PubMed ID: 32984917
    [No Abstract]   [Full Text] [Related]  

  • 22. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
    Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
    Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor.
    Prejac J; Dedić Plavetić N; Gotovac Jerčić K; Borovečki F
    World J Surg Oncol; 2021 Aug; 19(1):254. PubMed ID: 34452612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Li-Fraumeni syndrome].
    Sejben A; Tiszlavicz L; Polyák K; Kovács L; Maráz A; Török D; Leprán Á; Ottlakán A; Furák J
    Orv Hetil; 2019 Feb; 160(6):228-234. PubMed ID: 30730202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New knowledge of Li-Fraumeni syndrome].
    Funato M; Kondo N
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):148-53. PubMed ID: 23411951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parent decision-making around the genetic testing of children for germline TP53 mutations.
    Alderfer MA; Zelley K; Lindell RB; Novokmet A; Mai PL; Garber JE; Nathan D; Scollon S; Chun NM; Patenaude AF; Ford JM; Plon SE; Schiffman JD; Diller LR; Savage SA; Malkin D; Ford CA; Nichols KE
    Cancer; 2015 Jan; 121(2):286-93. PubMed ID: 25223899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of Li-Fraumeni syndrome, a hereditary cancer predisposition disorder.
    Miranda Alcalde B; Villa Alcázar M; Martínez Romera I; López Ibor B
    Arch Argent Pediatr; 2021 Feb; 119(1):e11-e17. PubMed ID: 33458985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
    Upton B; Chu Q; Li BD
    Surg Oncol Clin N Am; 2009 Jan; 18(1):145-56, ix. PubMed ID: 19056046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple primary cancers in families with Li-Fraumeni syndrome.
    Hisada M; Garber JE; Fung CY; Fraumeni JF; Li FP
    J Natl Cancer Inst; 1998 Apr; 90(8):606-11. PubMed ID: 9554443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
    Nemunaitis JM; Nemunaitis J
    Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
    Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
    J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.
    Masciari S; Van den Abbeele AD; Diller LR; Rastarhuyeva I; Yap J; Schneider K; Digianni L; Li FP; Fraumeni JF; Syngal S; Garber JE
    JAMA; 2008 Mar; 299(11):1315-9. PubMed ID: 18349092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome.
    Debelenko LV; Perez-Atayde AR; Dubois SG; Grier HE; Pai SY; Shamberger RC; Kozakewich HP
    Pediatr Dev Pathol; 2010; 13(3):218-24. PubMed ID: 20028212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
    Jouinot A; Bertherat J
    Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome.
    MacFarland SP; Zelley K; Long JM; McKenna D; Mamula P; Domchek SM; Nathanson KL; Brodeur GM; Rustgi AK; Katona BW; Maxwell KN
    Gastroenterology; 2019 Jan; 156(1):273-274. PubMed ID: 30243621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.